Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFerrexpo Regulatory News (FXPO)

  • This share is currently suspended. It was suspended at a price of 28.58

Share Price Information for Ferrexpo (FXPO)

Share Price is delayed by 15 minutes
Get Live Data
28.58    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £168.16m
FXPO Live PriceLast checked at - London Stock Exchange

Intraday Ferrexpo Share Chart

Holding(s) in Company

20 Mar 2009 17:15

RNS Number : 2520P
Ferrexpo PLC
20 March 2009
 



Form TR-1 with annex. FSA Version 2.1 updated April 2007

For filings with the FSA include the annex

For filings with issuer exclude the annex 

TR-1: Notifications of Major Interests in Shares

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

FERREXPO PLC

2. Reason for notification (yes/no)

An acquisition or disposal of voting rights

No

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached 

No

An event changing the breakdown of voting rights

No

Other (please specify):Execution of an agreement dated 18 March 2009 between Ralkon Commercial Limited and Fayver Properties Inc. relating to the voting of shares in the issuer held by each of the parties

Yes

3. Full name of person(s) subject to notification obligation:

RALKON COMMERCIAL LIMITED 

4. Full name of shareholder(s) (if different from 3):

IGOR KOLOMOISKY

5. Date of transaction (and date on which the threshold is crossed or reached if different):

18 March 2009

6. Date on which issuer notified:

20 March 2009

7. Threshold(s) that is/are crossed or reached:

10%

 

8: Notified Details

A: Voting rights attached to shares

Class/type of shares

If possible use ISIN code

GB00B1XH203

ORDINARY

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of shares

40,551,710

Number of voting rights

40,551,710

Number of shares

40,551,710

Number of voting rights

Percentage of voting rights

Direct

40,551,710

Indirect

18,691,205

Direct

6.8892%

Indirect

3.1754%

B: Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ conversion period/date 

No. of voting rights that may be acquired (if the instrument exercised/converted)

Percentage of voting rights

N/A

N/A

N/A

N/A

N/A

Total (A+B)

Number of voting rights

Percentage of voting rights

59,242,915

10.0646%

 

9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:

Ralkon Commercial Limited (40,551,710 shares, 6.8892% in Ferrexpo plc) - Igor Kolomoisky (100% beneficially held in Ralkon Commercial Limited)

An agreement has been concluded between Fayver Properties Inc. (holder of 18,691,205 shares, 3.1754% in Ferrexpo plc) and Ralkon Commercial Limited (holder of 40,551,710 shares, 6.8892% in Ferrexpo plc) under which the parties are bound to jointly exercise their voting rights in respect of shares in Ferrexpo plc

Proxy Voting:

10. Name of proxy holder:

N/A

11. Number of voting rights proxy holder will cease to hold:

N/A

12. Date on which proxy holder will cease to hold voting rights:

N/A

13. Additional information:

N/A

14 Contact name:

Mr Gavin Mackay

15. Contact telephone name:

+44 (0) 20 7389 8300

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLSEIFWSSUSESD
Date   Source Headline
1st Jul 202612:48 pmRNSReport on Payments to Governments to 31 Dec 2025
29th Jun 20266:00 pmRNSSuspended Company Notice - Deletion
29th Jun 20261:09 pmRNSResults of Annual General Meeting
29th Jun 20267:00 amRNSAGM Statement
29th May 20267:00 amRNSNotice of 2026 Annual General Meeting
28th Apr 20267:00 amRNSFunding Update and Delay in Financial Statements
22nd Apr 20267:00 amRNSUpdate on funding options
20th Apr 20267:00 amRNSSale of Iron Destiny and Update on Funding Options
15th Apr 20267:00 amRNSProduction Report for 1Q 2026
1st Apr 20269:41 amRNSTrading Update
9th Mar 20267:00 amRNSOperations and Corporate Update
2nd Mar 20268:20 amRNSDirector/PDMR Shareholding
24th Feb 20263:35 pmRNSUpdate regarding Ukrainian subsidiary
20th Jan 20263:39 pmRNSUpdate on operations in Ukraine
14th Jan 20267:00 amRNSProduction Report for 4Q 2025
31st Dec 20257:00 amRNS-REnd of year letter from Interim Executive Chair
31st Dec 20257:00 amRNS-REnd of year letter from Interim Executive Chair
14th Nov 20257:05 amRNSDirector Declaration
10th Nov 20257:00 amRNSLimited attack on power infrastructure
4th Nov 20257:00 amRNSPublication of Responsible Business Report
6th Oct 20257:00 amRNSProduction Report for 3Q 2025
11th Sep 202511:59 amRNSGeneral Meeting voting results
11th Aug 20257:00 amRNSPublication of Notice of General Meeting 2025
6th Aug 20257:00 amRNSInterim Results for six months ended 30 June 2025
7th Jul 20257:00 amRNSProduction Report for 2Q 2025
10th Jun 20254:48 pmRNSDirector/PDMR Shareholding
9th Jun 20254:35 pmRNSDirector/PDMR Shareholding
22nd May 202512:47 pmRNSResult of AGM
16th May 20255:00 pmRNSReport on Payments to Governments
15th May 202512:15 pmRNSUpdate regarding Ukrainian subsidiary
30th Apr 20257:00 amRNSLetter to shareholders re: auditor engagement
17th Apr 20255:32 pmRNSUkraine subsidiaries VAT refunds
10th Apr 20257:00 amRNSNotice of Annual General Meeting and 2024 ARA
7th Apr 20257:00 amRNSProduction Report for 1Q 2025
21st Mar 20257:00 amRNSStatement regarding Ukraine VAT refunds
19th Mar 20258:00 amRNSInternational Investment Agreements Notification
19th Mar 20257:00 amRNSFull Year Financial Results for 2024
11th Mar 20257:00 amRNSAnnouncement of Full Year 2024 Financial Results
5th Mar 20257:00 amRNSResponse to SBI Statement
4th Feb 20253:17 pmRNSUpdate regarding Ukrainian subsidiary
23rd Jan 20259:52 amRNSUpdate regarding Ukrainian Subsidiary
16th Jan 202511:30 amRNSUpdate regarding Ukrainian subsidiary
13th Jan 20257:00 amRNSResignation of Non-Executive Director
9th Jan 20257:00 amRNSProduction Report for 4Q 2024
30th Dec 20245:00 pmRNSPublication of Responsible Business Report
30th Dec 20245:00 pmRNSPublication of Climate Change Report
7th Oct 20247:00 amRNSProduction Report for 3Q 2024
19th Sep 202412:31 pmRNSGeneral Meeting voting results
12th Aug 20247:00 amRNSNotice of General Meeting 2024
5th Aug 20244:50 pmRNSUpdate on restrictions on shares in subsidiary

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.